SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-049020
Filing Date
2019-09-10
Accepted
2019-09-10 16:34:04
Documents
1
Period of Report
2019-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7358
  Complete submission text file 0001209191-19-049020.txt   8710
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address C/O NOVAVAX, INC. 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address
Herrmann John A III (Reporting) CIK: 0001610928 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 191085705